Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Intensive vasodilator therapy and coronary flow reserve in hypertension
2009-017831-16Phase 2Completed
- Sponsor
- Aarhus University Department of Biomedicine
- Start
- Jul 2010
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, single-arm trial of amlodipine, ramipril, lercanidipine and losartan in essential hypertension, sponsored by Aarhus University Department of Biomedicine. Primary endpoints: Coronary flow reserve and minimum vascular resistance and Left ventricular structure and function. Started Jul 2010; status: completed.
02
Drugs
amlodipineramiprillercanidipinelosartan
03
Conditions
essential hypertension
Beyond the preview
Go deeper on 2009-017831-16.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2009-017831-16.